| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/ANNRHEUMDIS-2013-204572 |
| P698 | PubMed publication ID | 24665112 |
| P50 | author | Ester Planas-Rigol | Q64539410 |
| José Hernández-Rodríguez | Q58399961 | ||
| P2093 | author name string | Ana García-Martínez | |
| Georgina Espígol-Frigolé | |||
| Itziar Tavera-Bahillo | |||
| Marco A Alba | |||
| Maria C Cid | |||
| Sergio Prieto-González | |||
| Marina Depetris | |||
| Josep M Grau | |||
| Franciso Lomeña | |||
| Marc Corbera-Bellata | |||
| P2860 | cites work | Retroperitoneal fibrosis | Q28292960 |
| Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients | Q33264062 | ||
| Diagnostic performance of ¹⁸F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis | Q33895383 | ||
| Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients | Q33993390 | ||
| Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients | Q34283592 | ||
| Clinical features of polymyalgia rheumatica and giant cell arteritis | Q38028863 | ||
| Diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin: a meta-analysis | Q38103439 | ||
| Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio | Q43936771 | ||
| Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms | Q46524647 | ||
| Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. | Q50933050 | ||
| Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. | Q51723974 | ||
| Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. | Q51769966 | ||
| The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. | Q53142320 | ||
| Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. | Q53179293 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| positron emission tomography | Q208376 | ||
| giant cell arteritis | Q707816 | ||
| P304 | page(s) | 1388-1392 | |
| P577 | publication date | 2014-03-24 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study | |
| P478 | volume | 73 |
| Q52983704 | 18F-FDG uptake in main arterial branches of patients with large vessel vasculitis: visual and semiquantitative analysis. |
| Q37077859 | 18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: A multicenter cohort of 130 patients |
| Q89029803 | Arterial lesions in giant cell arteritis: A longitudinal study |
| Q91704989 | Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions |
| Q51730618 | CT analysis of the aorta in giant-cell arteritis: a case-control study. |
| Q90911186 | Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis |
| Q52718727 | Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis. |
| Q52983767 | Contrast-Enhanced Ultrasound of the Carotid Artery in Patients With Large Vessel Vasculitis: Correlation With Positron Emission Tomography Findings. |
| Q50082820 | Current and emerging therapies in large-vessel vasculitis |
| Q30251992 | Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis : A meta-analysis |
| Q88178216 | Diagnostic and treatment challenges in giant cell arteritis |
| Q50016407 | Diese unglaubliche Müdigkeit und immer wieder abends Fieber und Kopfschmerzen |
| Q36256143 | Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization |
| Q36152152 | Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study |
| Q54238129 | FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. |
| Q26865857 | Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography |
| Q37077856 | Giant-cell arteritis without cranial manifestations: Working diagnosis of a distinct disease pattern. |
| Q37175714 | MRI parametric monitoring of biological therapies in primary large vessel vasculitides: a pilot study |
| Q53588050 | Magnetic Resonance Imaging of Temporal Arteritis: A Case Report. |
| Q26852724 | Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis |
| Q33879740 | Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol. |
| Q47836073 | Positron Emission Tomography as an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients with Large Vessel Vasculitis. |
| Q37605575 | Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study. |
| Q93062171 | Primary Angiitis of the Central Nervous System: New Potential Imaging Techniques and Biomarkers in Blood and Cerebrospinal Fluid |
| Q52611166 | Recent Advances in Giant Cell Arteritis. |
| Q92712893 | Semiquantitative Interpretation Criteria for Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Large-Vessel Vasculitis: Pattern Recognition and Correlation with Polymyalgia Rheumatica |
| Q90678634 | Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study |
| Q90150340 | The Clinical Impact of Using 18F-FDG-PET/CT in the Diagnosis of Suspected Vasculitis: The Effect of Dose and Timing of Glucocorticoid Treatment |
| Q38547761 | The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis |
| Q90620722 | The Role of Vascular Imaging to Advance Clinical Care and Research in Large-Vessel Vasculitis |
| Q40144137 | The prognostic value of baseline (18)F-FDG PET/CT in steroid-naïve large-vessel vasculitis: introduction of volume-based parameters. |
| Q40213214 | The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: A retrospective study. |
| Q52578815 | Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. |
| Q47617064 | [18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic. |
| Q54681683 | [Large vessel vasculitis : Giant cell arteritis and Takayasu arteritis]. |
Search more.